Michael E. Borden

Jul 31, 2024 | lexology.com | James Lowe |Benjamin R. Nagin |Patrick Harrison |Michael E. Borden |Monika Zdzieborska

Click here to watch the video. This session will cover key regulatory developments amid increased interest and scrutiny from global antitrust and competition agencies, as well as touch on the impact of AI on U.S. private litigation.

Jun 12, 2024 | lexology.com | Chen Yang |Michael E. Borden

Since late 2023, the Chinese government has been providing policy and regulatory clarifications to encourage foreign investments and streamline their China operations in the life sciences industry. As we have discussed, there are geopolitical challenges in the relationship between the U.S. and the China biotech industry right now. Nevertheless, , large U.S. pharmaceutical companies have expressed their commitment to doing business in China.

Nov 7, 2023 | datamatters.sidley.com | Michael E. Borden |Colleen Brown |Sharon Flanagan |David Gordon

On October 30, 2023, President Joe Biden issued an executive order (EO or the Order) on Safe, Secure, and Trustworthy Artificial Intelligence (AI) to advance a coordinated, federal governmentwide approach toward the safe and responsible development of AI.

Nov 6, 2023 | lexology.com | Michael E. Borden |Colleen Brown |Sharon Flanagan |David Gordon |Robert Keeling |David Lashway | +2 more

Table of ContentsOverviewKey DirectivesPrivacyEquity and Civil RightsIntellectual PropertySteps AheadOverviewOn October 30, 2023, President Joe Biden issued an executive order (EO or the Order) on Safe, Secure, and Trustworthy Artificial Intelligence (AI) to advance a coordinated, federal governmentwide approach toward the safe and responsible development of AI.

Jul 26, 2023 | datamatters.sidley.com | Michael E. Borden |Lilya Tessler |David E Teitelbaum |Kate L. Lashley

This week, two committees in the House of Representatives will mark up legislation intended to clarify the regulatory framework applicable to digital assets in the United States.